Digital health plays a growing role across Europe despite the fact that there are still many uncertainties regarding its technical, legal, ethical and financial aspects. Mobile Health (mHealth) in particular, enabled through smartphones, tablets and computers,...
Since the last EU Action Plan on Antimicrobial Resistance (AMR) expired at the end of 2016, the EU now has the opportunity to increase efforts further and ensure that the follow-up Action Plan, to be released in June 2017, builds upon existing strategies to more...
EPHA seeks to provide evidence of the threats posed by CETA to public health in this Position Paper. In the document, EPHA does not limit its reflection to highlighting the risks, but aims to provide decision makers with a set of clear asks and suggestions on what...
A new EPHA Position Paper on the possible impact of TTIP on the consumption of tobacco and the implications for public health. Tobacco products are unique in the scale and severity of the public health impacts they cause worldwide. Tobacco products are toxic,...
EPHA Position on Investment Protection in TTIP and Trade Agreements: Response to the European Commission proposal for an Investment Court System to replace Investor-to-State Dispute Settlement (ISDS) EPHA welcomes the European Commission’s decision to move away...
The objective of the European Public Health Community is to protect and promote public health by ensuring policy and regulatory space for governments and the EU by incorporating flexibility: Improved well-being of people should be the primary objective of EU policies,...